This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Fu Ou-Yang: Innovator in Protein Targeting for Therapeutic Applications
Introduction
Fu Ou-Yang is a commendable inventor based in Houston, Texas, recognized for his contributions to the field of biotechnology. With a keen focus on developing innovative solutions to combat serious health conditions, Fu has proven himself as an influential figure in his area of expertise.
Latest Patents
Fu Ou-Yang holds a notable patent titled "Targeting proteins to deliver therapeutic or diagnostic reagents." This invention revolves around compositions that comprise an angiogenesis inhibitor coupled with either a therapeutic or diagnostic agent. Specifically, the patent details the innovative use of fusion genes or fusion gene products that encode the angiogenesis inhibitor, aimed at treating angiogenesis-related diseases, such as cancer. This groundbreaking work has the potential to enhance the efficacy of treatments and improve patient outcomes.
Career Highlights
Fu is affiliated with the University of Texas System, where he leverages his knowledge and expertise to contribute to cutting-edge research and innovation. His work aligns with the mission of the University to advance health and improve lives through technology and science.
Collaborations
Throughout his career, Fu Ou-Yang has collaborated with esteemed colleagues, including Mien-Chie Hung and Keng-Li Lan. These partnerships have fostered a dynamic environment for research and innovation, ultimately leading to advancements in therapeutic strategies and biomedical applications.
Conclusion
Fu Ou-Yang stands out as a dedicated inventor whose work in targeting proteins has the potential to revolutionize treatment options for patients with angiogenesis-related diseases. His ongoing contributions to the field, paired with his collaborative spirit, highlight the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
